Accumulation of pathological tau species and memory loss in a conditional model of tauopathy

Zdenek Berger, Hanno Roder, Amanda Hanna, Aaron Carlson, Vijayaraghavan Rangachari, Mei Yue, Zbigniew Wszolek, Karen H Ashe, Joshua Knight, Dennis Dickson, Cathy Andorfer, Terrone L. Rosenberry, Jada Lewis, Mike Hutton, Christopher Janus

Research output: Contribution to journalArticle

299 Citations (Scopus)

Abstract

Neurofibrillary tangles (NFTs) are a pathological hallmark of Alzheimer's disease and other tauopathies, but recent studies in a conditional mouse model of tauopathy (rTg4510) have suggested that NFT formation can be dissociated from memory loss and neurodegeneration. This suggests that NFTs are not the major neurotoxic tau species, at least during the early stages of pathogenesis. To identify other neurotoxic tau protein species, we performed biochemical analyses on brain tissues from the rTg4510 mouse model and then correlated the levels of these tau proteins with memory loss. We describe the identification and characterization of two forms of tau multimers (140 and 170 kDa), whose molecular weight suggests an oligomeric aggregate, that accumulate early in the pathogenic cascade in this mouse model. Similar tau multimers were detected in a second mouse model of tauopathy (JNPL3) and in tissue from patients with Alzheimer's disease and FTDP-17 (frontotemporal dementia and parkinsonism linked to chromosome 17). Moreover, levels of the tau multimers correlated consistently with memory loss at various ages in the rTg4510 mouse model. Our findings suggest that accumulation of early-stage aggregated tau species, before the formation of NFT, is associated with the development of functional deficits during the pathogenic progression of tauopathy.

Original languageEnglish (US)
Pages (from-to)3650-3662
Number of pages13
JournalJournal of Neuroscience
Volume27
Issue number14
DOIs
StatePublished - Apr 4 2007

Fingerprint

Tauopathies
Memory Disorders
Neurofibrillary Tangles
tau Proteins
Alzheimer Disease
Frontotemporal Dementia
Chromosomes, Human, Pair 17
Parkinsonian Disorders
Molecular Weight
Brain

Keywords

  • Alzheimer's disease
  • FTDP-17
  • Neurodegeneration
  • Tau
  • Toxicity
  • Transgenic

Cite this

Berger, Z., Roder, H., Hanna, A., Carlson, A., Rangachari, V., Yue, M., ... Janus, C. (2007). Accumulation of pathological tau species and memory loss in a conditional model of tauopathy. Journal of Neuroscience, 27(14), 3650-3662. https://doi.org/10.1523/JNEUROSCI.0587-07.2007

Accumulation of pathological tau species and memory loss in a conditional model of tauopathy. / Berger, Zdenek; Roder, Hanno; Hanna, Amanda; Carlson, Aaron; Rangachari, Vijayaraghavan; Yue, Mei; Wszolek, Zbigniew; Ashe, Karen H; Knight, Joshua; Dickson, Dennis; Andorfer, Cathy; Rosenberry, Terrone L.; Lewis, Jada; Hutton, Mike; Janus, Christopher.

In: Journal of Neuroscience, Vol. 27, No. 14, 04.04.2007, p. 3650-3662.

Research output: Contribution to journalArticle

Berger, Z, Roder, H, Hanna, A, Carlson, A, Rangachari, V, Yue, M, Wszolek, Z, Ashe, KH, Knight, J, Dickson, D, Andorfer, C, Rosenberry, TL, Lewis, J, Hutton, M & Janus, C 2007, 'Accumulation of pathological tau species and memory loss in a conditional model of tauopathy', Journal of Neuroscience, vol. 27, no. 14, pp. 3650-3662. https://doi.org/10.1523/JNEUROSCI.0587-07.2007
Berger, Zdenek ; Roder, Hanno ; Hanna, Amanda ; Carlson, Aaron ; Rangachari, Vijayaraghavan ; Yue, Mei ; Wszolek, Zbigniew ; Ashe, Karen H ; Knight, Joshua ; Dickson, Dennis ; Andorfer, Cathy ; Rosenberry, Terrone L. ; Lewis, Jada ; Hutton, Mike ; Janus, Christopher. / Accumulation of pathological tau species and memory loss in a conditional model of tauopathy. In: Journal of Neuroscience. 2007 ; Vol. 27, No. 14. pp. 3650-3662.
@article{f6e2224061ea4c0aa5b30984cf6e707b,
title = "Accumulation of pathological tau species and memory loss in a conditional model of tauopathy",
abstract = "Neurofibrillary tangles (NFTs) are a pathological hallmark of Alzheimer's disease and other tauopathies, but recent studies in a conditional mouse model of tauopathy (rTg4510) have suggested that NFT formation can be dissociated from memory loss and neurodegeneration. This suggests that NFTs are not the major neurotoxic tau species, at least during the early stages of pathogenesis. To identify other neurotoxic tau protein species, we performed biochemical analyses on brain tissues from the rTg4510 mouse model and then correlated the levels of these tau proteins with memory loss. We describe the identification and characterization of two forms of tau multimers (140 and 170 kDa), whose molecular weight suggests an oligomeric aggregate, that accumulate early in the pathogenic cascade in this mouse model. Similar tau multimers were detected in a second mouse model of tauopathy (JNPL3) and in tissue from patients with Alzheimer's disease and FTDP-17 (frontotemporal dementia and parkinsonism linked to chromosome 17). Moreover, levels of the tau multimers correlated consistently with memory loss at various ages in the rTg4510 mouse model. Our findings suggest that accumulation of early-stage aggregated tau species, before the formation of NFT, is associated with the development of functional deficits during the pathogenic progression of tauopathy.",
keywords = "Alzheimer's disease, FTDP-17, Neurodegeneration, Tau, Toxicity, Transgenic",
author = "Zdenek Berger and Hanno Roder and Amanda Hanna and Aaron Carlson and Vijayaraghavan Rangachari and Mei Yue and Zbigniew Wszolek and Ashe, {Karen H} and Joshua Knight and Dennis Dickson and Cathy Andorfer and Rosenberry, {Terrone L.} and Jada Lewis and Mike Hutton and Christopher Janus",
year = "2007",
month = "4",
day = "4",
doi = "10.1523/JNEUROSCI.0587-07.2007",
language = "English (US)",
volume = "27",
pages = "3650--3662",
journal = "Journal of Neuroscience",
issn = "0270-6474",
publisher = "Society for Neuroscience",
number = "14",

}

TY - JOUR

T1 - Accumulation of pathological tau species and memory loss in a conditional model of tauopathy

AU - Berger, Zdenek

AU - Roder, Hanno

AU - Hanna, Amanda

AU - Carlson, Aaron

AU - Rangachari, Vijayaraghavan

AU - Yue, Mei

AU - Wszolek, Zbigniew

AU - Ashe, Karen H

AU - Knight, Joshua

AU - Dickson, Dennis

AU - Andorfer, Cathy

AU - Rosenberry, Terrone L.

AU - Lewis, Jada

AU - Hutton, Mike

AU - Janus, Christopher

PY - 2007/4/4

Y1 - 2007/4/4

N2 - Neurofibrillary tangles (NFTs) are a pathological hallmark of Alzheimer's disease and other tauopathies, but recent studies in a conditional mouse model of tauopathy (rTg4510) have suggested that NFT formation can be dissociated from memory loss and neurodegeneration. This suggests that NFTs are not the major neurotoxic tau species, at least during the early stages of pathogenesis. To identify other neurotoxic tau protein species, we performed biochemical analyses on brain tissues from the rTg4510 mouse model and then correlated the levels of these tau proteins with memory loss. We describe the identification and characterization of two forms of tau multimers (140 and 170 kDa), whose molecular weight suggests an oligomeric aggregate, that accumulate early in the pathogenic cascade in this mouse model. Similar tau multimers were detected in a second mouse model of tauopathy (JNPL3) and in tissue from patients with Alzheimer's disease and FTDP-17 (frontotemporal dementia and parkinsonism linked to chromosome 17). Moreover, levels of the tau multimers correlated consistently with memory loss at various ages in the rTg4510 mouse model. Our findings suggest that accumulation of early-stage aggregated tau species, before the formation of NFT, is associated with the development of functional deficits during the pathogenic progression of tauopathy.

AB - Neurofibrillary tangles (NFTs) are a pathological hallmark of Alzheimer's disease and other tauopathies, but recent studies in a conditional mouse model of tauopathy (rTg4510) have suggested that NFT formation can be dissociated from memory loss and neurodegeneration. This suggests that NFTs are not the major neurotoxic tau species, at least during the early stages of pathogenesis. To identify other neurotoxic tau protein species, we performed biochemical analyses on brain tissues from the rTg4510 mouse model and then correlated the levels of these tau proteins with memory loss. We describe the identification and characterization of two forms of tau multimers (140 and 170 kDa), whose molecular weight suggests an oligomeric aggregate, that accumulate early in the pathogenic cascade in this mouse model. Similar tau multimers were detected in a second mouse model of tauopathy (JNPL3) and in tissue from patients with Alzheimer's disease and FTDP-17 (frontotemporal dementia and parkinsonism linked to chromosome 17). Moreover, levels of the tau multimers correlated consistently with memory loss at various ages in the rTg4510 mouse model. Our findings suggest that accumulation of early-stage aggregated tau species, before the formation of NFT, is associated with the development of functional deficits during the pathogenic progression of tauopathy.

KW - Alzheimer's disease

KW - FTDP-17

KW - Neurodegeneration

KW - Tau

KW - Toxicity

KW - Transgenic

UR - http://www.scopus.com/inward/record.url?scp=34147125835&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34147125835&partnerID=8YFLogxK

U2 - 10.1523/JNEUROSCI.0587-07.2007

DO - 10.1523/JNEUROSCI.0587-07.2007

M3 - Article

C2 - 17409229

AN - SCOPUS:34147125835

VL - 27

SP - 3650

EP - 3662

JO - Journal of Neuroscience

JF - Journal of Neuroscience

SN - 0270-6474

IS - 14

ER -